Trials / Completed
CompletedNCT02492412
Efficacy and Safety of HE10 for Dry Eye Syndrome
Multi-center, Randomized, Double-blind, Active Comparator- Controlled, Parallel Study Evaluating the Efficacy and Safety of HE10 in Subjects With Dry Eye Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of HE10 eye drop for the patients with moderate to severe dry eye syndrome.
Detailed description
This study is to compare the efficacy and safety of HE10 and Restasis for patients with moderate to severe dry eye syndrome in multi-center, double-blind, randomized, active comparator-controlled, parallel design, non-inferiority Phase III clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HE 10 | |
| DRUG | Restasis |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-07-01
- Completion
- 2014-09-01
- First posted
- 2015-07-08
- Last updated
- 2015-07-08
Source: ClinicalTrials.gov record NCT02492412. Inclusion in this directory is not an endorsement.